Recurrent breast carcinoma after prior intensive therapy responsive to biochemical modulation of 5-FU with low-dose cisplatin:Case report
スポンサーリンク
概要
- 論文の詳細を見る
A 53-year-old woman with breast carcinoma underwent modified radical mastectomy and intensive adjuvant chemoendocrine therapy (including CAF therapy), but developed bone metastasis. After resection of the metastatic focus and further chemoendocrine therapy, she developed multiple bone metastases and pain in the right upper arm. One course of 5-fluorouracil combined with low-dose cisplatin achieved remarkable pain relief and new calcification of the lytic lesion in the humerus. There were no major side effects of this therapy. Unfortunately, spinal cord injury due to vertebral compression fracture forced us to discontinue treatment, so the duration of partial remission was less than two months. However, the response to this modulation regimen in a patient with very intensive prior therapy is notable.
- 日本癌病態治療研究会の論文
日本癌病態治療研究会 | 論文
- Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy
- Endoscopic Mucosal Resection (EMR) for Colorectal Lesions and Lesion-lifted Condition as an Indicator of the Tumor Invasion
- NOVEL APPROACH TO IMMUNOTHERAPY FOR EPITHELIAL CANCERS, BONE AND SOFT-TISSUE SARCOMAS
- Extracellular heat shock proteins (eHSPs) pilot exogenous antigen into cross-presentation pathway: A superguide from extracellular world to intracellular tour
- Preoperative body mass index and outcomes of gastric cancer patients